Addressing the shortfalls of LNP-based delivery with conjugate modalities

“Good products are born of good science, and good science takes time, patience, and vision.”

On April 4, 2025, Lauren Coyle, Launch Commissioning Editor, Bioconjugation Insights, spoke to Moein Moghimi, Professor of Pharmaceutics and Nanomedicine, Newcastle University and Adjoint Professor, Skaggs School of Pharmacy, University of Colorado Anschutz Medical Campus, about the evolution of conjugates to overcome lipid nanoparticle limitations. This article is based on that interview.

Please enter your email to access content Read now